Cardinal George to participate in a clinical research to fight cancer

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.
Data pix.

The archdiocese of Chicago has released the following information regarding Cardinal Francis George’s health.

Cardinal Francis George continues to undergo cancer treatment with doctors at Loyola University Medical Center. The Cardinal recently underwent a regular medical procedure there to replace a stent in his ureter. This procedure has been done routinely every six months over the last few years.

Additionally, Cardinal George has agreed to participate in a clinical research trial at University of Chicago Medicine. The trial is testing a new drug, which may work by activating cells of the immune system enabling them to attack cancer cells. This approach differs from that of traditional chemotherapy, which uses drugs designed to be toxic to cancer cells.  A preliminary trial of this new drug has shown promising results for patients who have the same type of cancer as Cardinal George. The current study seeks to confirm these results in a larger number of patients.

The Cardinal is continuing to maintain his regular schedule. Since the Cardinal is just beginning this new treatment we have limited information at this time. We will continue to share information about his medical status.

The Cardinal is grateful to those who are praying for him and requests that everyone continue to remember him in their thoughts and prayers.


Latest News

More News